Odimma Therapeutics will participate in BIO-Europe Spring 2024, taking place in Barcelona from March 18–20, 2024.
The event brings together biotechnology companies, investors, pharmaceutical leaders and innovation partners from across the international life sciences ecosystem.
Participation in BIO-Europe Spring reflects Odimma Therapeutics’ continued commitment to expanding strategic collaborations and increasing the international visibility of its personalized immunotherapy platform combining AI-driven neoantigen selection and synthetic DNA technologies.
The company looks forward to engaging with potential partners, investors and industry stakeholders during the event.
